Targeting IL-17 in psoriasis: From cutaneous immunobiology to clinical application

被引:41
作者
Ariza, Maria-Eugenia [1 ,2 ]
Williams, Marshall V. [1 ,2 ]
Wong, Henry K. [3 ]
机构
[1] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
[2] Ohio State Univ, Med Ctr, Inst Behav Med Res, Columbus, OH 43210 USA
[3] Ohio State Univ, Med Ctr, Dept Internal Med, Div Dermatol, Columbus, OH 43210 USA
关键词
Psoriasis; IL-17; T cells; T(H)17; Therapy; Inflammation; GENOME-WIDE ASSOCIATION; T-HELPER TYPE-1; DENDRITIC CELLS; SUSCEPTIBILITY LOCUS; MONOCLONAL-ANTIBODY; THERAPEUTIC TARGET; VULGARIS LESIONS; T(H)17 CYTOKINE; INTERLEUKIN; 22; SKIN-LESIONS;
D O I
10.1016/j.clim.2012.12.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Psoriasis vulgaris is a chronic, immune-mediated inflammatory skin disease associated with complex genetic susceptibility. Although the hallmark of psoriasis is characterized by cutaneous inflammation and keratinocyte hyperproliferation, recent studies show that the pathologic features observed in psoriasis arises as a result of innate and adaptive immune activation in genetically prone individuals. Studies focused on the microenvironment in the skin of psoriasis lesions have revealed novel cellular and cytokine abnormalities of the immune system. One pathway important is the role of the T(H)17/IL-17 dysregulation. The recent development of biologics that target the IL-17 cytokine pathway has confirmed the importance of T(H)17 and IL-17 homeostasis in the skin and yielded potent therapies in the treatment of psoriasis, and potentially other autoimmune diseases. (c) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 99 条
[1]   Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells [J].
Acosta-Rodriguez, Eva V. ;
Napolitani, Giorgio ;
Lanzavecchia, Antonio ;
Sallusto, Federica .
NATURE IMMUNOLOGY, 2007, 8 (09) :942-949
[2]   Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells [J].
Ahern, Philip P. ;
Schiering, Chris ;
Buonocore, Sofia ;
McGeachy, Mandy J. ;
Cua, Dan J. ;
Maloy, Kevin J. ;
Powrie, Fiona .
IMMUNITY, 2010, 33 (02) :279-288
[3]   Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A [J].
Al-Daraji, WI ;
Grant, KR ;
Ryan, K ;
Saxton, A ;
Reynolds, NJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (05) :779-788
[4]   A Human Endogenous Retrovirus K dUTPase Triggers a TH1, TH17 Cytokine Response: Does It Have a Role in Psoriasis? [J].
Ariza, Maria-Eugenia ;
Williams, Marshall V. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (12) :2419-2427
[5]   Psoriasis susceptibility locus on 18p revealed by genome scan in Finnish families not associated with PSORS1 [J].
Asumalahti, K ;
Laitinen, T ;
Lahermo, P ;
Suomela, S ;
Itkonen-Vatjus, R ;
Jansen, C ;
Karvonen, J ;
Karvonen, SL ;
Reunala, T ;
Snellman, E ;
Uurasmaa, T ;
Saarialho-Kere, U ;
Kere, J .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2003, 121 (04) :735-740
[6]   The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-γ, interleukin-2, and tumor necrosis factor-α, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations:: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients [J].
Austin, LM ;
Ozawa, M ;
Kikuchi, T ;
Walters, IB ;
Krueger, JG .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (05) :752-759
[7]   Immunobiology of dendritic cells [J].
Banchereau, J ;
Briere, F ;
Caux, C ;
Davoust, J ;
Lebecque, S ;
Liu, YT ;
Pulendran, B ;
Palucka, K .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :767-+
[8]   IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes [J].
Boniface, K ;
Bernard, FX ;
Garcia, M ;
Gurney, AL ;
Lecron, JC ;
Morel, F .
JOURNAL OF IMMUNOLOGY, 2005, 174 (06) :3695-3702
[9]   Getting under the skin: The immunogenetics of psoriasis [J].
Bowcock, AM ;
Krueger, JG .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (09) :699-711
[10]  
Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001